Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Eagle Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
EGRX
Nasdaq
2834
https://www.eagleus.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Eagle Pharmaceuticals Inc
Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio
- Jan 18th, 2024 11:50 am
Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City
- Dec 6th, 2023 9:05 pm
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q
- Nov 29th, 2023 12:35 pm
Eagle Pharmaceuticals Announces Management Change
- Nov 29th, 2023 12:30 pm
Down -33.75% in 4 Weeks, Here's Why Eagle Pharmaceuticals (EGRX) Looks Ripe for a Turnaround
- Nov 27th, 2023 2:35 pm
Down -26.73% in 4 Weeks, Here's Why Eagle Pharmaceuticals (EGRX) Looks Ripe for a Turnaround
- Nov 10th, 2023 2:35 pm
Eagle Delays Third Quarter 2023 Results and Conference Call
- Nov 9th, 2023 12:30 pm
Eagle Pharmaceuticals to Host Third Quarter 2023 Financial Results on November 9, 2023
- Nov 8th, 2023 1:30 pm
Canopy Growth Corporation (CGC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
- Nov 2nd, 2023 2:00 pm
Eagle Pharmaceuticals Granted Patent for PEMFEXY®
- Oct 24th, 2023 12:40 pm
Eagle Pharmaceuticals Granted Unique J-Code and Pass-Through Status for BARHEMSYS® from CMS
- Oct 23rd, 2023 10:50 am
Implied Volatility Surging for Eagle Pharmaceuticals (EGRX) Stock Options
- Oct 13th, 2023 12:36 pm
Shareholders in Eagle Pharmaceuticals (NASDAQ:EGRX) are in the red if they invested five years ago
- Oct 12th, 2023 11:23 am
Eagle Pharmaceuticals Awarded First Prize for Poster to Be Presented at the International Society for Anaesthetic Pharmacology 32nd Annual Meeting
- Oct 4th, 2023 10:50 am
Eagle Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023
- Sep 19th, 2023 8:05 pm
Eagle Pharmaceuticals to Present BYFAVO® (remimazolam) for Injection Abstract at Prestigious Society for Neuroscience in Anesthesiology and Critical Care (SNACC) Conference
- Aug 30th, 2023 10:50 am
Eagle Pharmaceuticals Announces Positive Type C Meeting with FDA for EA-114, an Estrogen Receptor Antagonist Used in the Treatment of Metastatic Breast Cancer in Post-Menopausal Women
- Aug 29th, 2023 10:50 am
Eagle Pharmaceuticals to Present at Two Upcoming Healthcare Conferences
- Aug 22nd, 2023 8:05 pm
Eagle Pharmaceuticals Reiterates 2023 Adjusted non-GAAP EBITDA and Adjusted non-GAAP E¹ Guidance
- Aug 17th, 2023 10:50 am
Is Eagle Pharmaceuticals (EGRX) Stock Undervalued Right Now?
- Aug 11th, 2023 1:40 pm
Scroll